Takeda Pharmaceutical Co. Ltd. · TSE:4502
Farajallah Awny Samaan Botros received 17,554 Takeda Pharmaceutical Co. Ltd. shares as an award (Form 4)
Traded Jul 1, 2026 · Filed Jul 6, 2026
On Jul 1, 2026, Farajallah Awny Samaan Botros (Chief Medical Officer) received 17,554 Takeda Pharmaceutical Co. Ltd. shares as an award, leaving 130,183 shares. Filed Jul 6, 2026 (Form 4).
- Awarded
- 17,554 shares
- Holding after
- 130,183 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | American Depositary Shares | Award | 17,554 | 130,183 | Direct |
Source
Related
- Takeda Pharmaceutical Co. Ltd.
- Farajallah Awny Samaan Botros
- Takeda Pharmaceutical Co. Ltd. shareholders
- Form 4 · Farajallah Awny Samaan Botros · Aug 12, 2026
- Form 4 · Duprey Lauren Rusckowski · Sep 15, 2026
- Form 4 · Plump Andrew Stewart · Sep 3, 2026
- Form 4 · Plump Andrew Stewart · Aug 21, 2026
- Form 4 · Greenway Nicola Deidre Petal · Aug 19, 2026
- Form 4 · Shannon Elaine Mary · Aug 12, 2026